ARGX — argenx SE Income Statement
0.000.00%
HealthcareBalancedLarge CapNeutral
- $22.34bn
- $20.16bn
- $410.75m
- 52
- 10
- 73
- 41
Annual income statement for argenx SE, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 25.3 | 78.5 | 41.2 | 497 | 411 |
Cost of Revenue | |||||
Gross Profit | — | — | — | — | 381 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 122 | 277 | 519 | 846 | 1,131 |
Operating Profit | -96.5 | -199 | -478 | -349 | -720 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -77.7 | -176 | -605 | -400 | -729 |
Provision for Income Taxes | |||||
Net Income After Taxes | -78.6 | -181 | -608 | -408 | -710 |
Net Income Before Extraordinary Items | |||||
Net Income | -78.6 | -181 | -608 | -408 | -710 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -78.6 | -181 | -608 | -408 | -710 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.35 | -4.69 | -13.4 | -7.99 | -13 |
Dividends per Share |